Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Statistics

Total Valuation

CSE:DOSE has a market cap or net worth of CAD 21.35 million. The enterprise value is 26.56 million.

Market Cap	21.35M
Enterprise Value	26.56M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:DOSE has 133.46 million shares outstanding. The number of shares has increased by 15.90% in one year.

Current Share Class	133.46M
Shares Outstanding	133.46M
Shares Change (YoY)	+15.90%
Shares Change (QoQ)	+4.47%
Owned by Insiders (%)	15.72%
Owned by Institutions (%)	n/a
Float	112.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.65
PB Ratio	-4.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.45
EV / Sales	10.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.52

Financial Position

The company has a current ratio of 0.06

Current Ratio	0.06
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-5.47
Interest Coverage	-3.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-80.16%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	69.96%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.85
Inventory Turnover	5.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.76% in the last 52 weeks. The beta is -0.59, so CSE:DOSE's price volatility has been lower than the market average.

Beta (5Y)	-0.59
52-Week Price Change	-45.76%
50-Day Moving Average	0.17
200-Day Moving Average	0.19
Relative Strength Index (RSI)	43.89
Average Volume (20 Days)	28,633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:DOSE had revenue of CAD 2.47 million and -4.87 million in losses. Loss per share was -0.04.

Revenue	2.47M
Gross Profit	1.32M
Operating Income	-3.72M
Pretax Income	-4.87M
Net Income	-4.87M
EBITDA	-3.52M
EBIT	-3.72M
Loss Per Share	-0.04

Balance Sheet

The company has 72,497 in cash and 5.28 million in debt, giving a net cash position of -5.21 million or -0.04 per share.

Cash & Cash Equivalents	72,497
Total Debt	5.28M
Net Cash	-5.21M
Net Cash Per Share	-0.04
Equity (Book Value)	-5.32M
Book Value Per Share	-0.04
Working Capital	-8.71M

Cash Flow

In the last 12 months, operating cash flow was -959,368 and capital expenditures -5,740, giving a free cash flow of -965,108.

Operating Cash Flow	-959,368
Capital Expenditures	-5,740
Free Cash Flow	-965,108
FCF Per Share	-0.01

Margins

Gross margin is 53.26%, with operating and profit margins of -150.80% and -197.30%.

Gross Margin	53.26%
Operating Margin	-150.80%
Pretax Margin	-197.30%
Profit Margin	-197.30%
EBITDA Margin	-142.66%
EBIT Margin	-150.80%
FCF Margin	n/a

Dividends & Yields

CSE:DOSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.90%
Shareholder Yield	-15.90%
Earnings Yield	-22.81%
FCF Yield	-4.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:DOSE has an Altman Z-Score of -19.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.32
Piotroski F-Score	2